Pfizer (PFE) news
Recent news
Fitch affirms Epif at 'BBB'; outlook stable
Fitch Ratings has affirmed its credit rating for Epif at 'BBB', with a stable outlook, reflecting the company's solid financial position and operational performance. The rating underscores Fitch's confidence in Epif's ability to maintain its creditworthiness amid evolving market conditions. The…
AInvest Wire · 22h agoPfizer showcases clinical advancements across infectious diseases at IDWeek 2026
AInvest Wire · 1d agoEnodia, Pfizer pact has potential value of more than $500M
Pharmaceutical company Pfizer Inc. (NYSE: PFE) has entered into a collaboration agreement with Enodia Therapeutics, a clinical-stage biotechnology firm, to develop and commercialize a novel therapeutic candidate. The partnership, which encompasses research, development, and potential…
AInvest Wire · 2d agoEnodia Therapeutics: Pfizer will be responsible for all clinical, manufacturing, regulatory and commercial activities
AInvest Wire · 2d agoEnodia Therapeutics announces research collaboration and license agreement with Pfizer to develop SEC61-targeting small molecules
AInvest Wire · 2d agoLight Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.